Guard Therapeutics International AB (publ) (STO:GUARD)
1.540
+0.142 (10.16%)
Jun 11, 2026, 5:29 PM CET
STO:GUARD Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 41 | 49.83 | 54.19 | 83.74 | 201.01 | 188.61 |
Cash & Short-Term Investments | 41 | 49.83 | 54.19 | 83.74 | 201.01 | 188.61 |
Cash Growth | 154.69% | -8.05% | -35.29% | -58.34% | 6.58% | 109.46% |
Other Receivables | 0.35 | 0.6 | 0.42 | 0.67 | 0.9 | 0.93 |
Receivables | 0.35 | 0.6 | 0.42 | 0.67 | 0.9 | 0.93 |
Prepaid Expenses | 3.66 | 3.72 | 1.13 | 0.82 | 0.69 | 0.87 |
Other Current Assets | -0 | - | -0 | - | 0 | - |
Total Current Assets | 45 | 54.14 | 55.74 | 85.23 | 202.59 | 190.41 |
Property, Plant & Equipment | - | - | - | - | 0.02 | 0.03 |
Other Long-Term Assets | - | - | - | - | -0 | - |
Total Assets | 45 | 54.14 | 55.74 | 85.23 | 202.61 | 190.44 |
Accounts Payable | 1.92 | 3.35 | 9.43 | 5.49 | 11.22 | 6.29 |
Accrued Expenses | 4.07 | 6.45 | 7.92 | 10.56 | 10.79 | 3.92 |
Current Income Taxes Payable | - | - | 0.08 | 0.27 | 0.39 | 0.27 |
Other Current Liabilities | 0.31 | 0.3 | 0.31 | 0.29 | 0.29 | 0.47 |
Total Current Liabilities | 6.31 | 10.1 | 17.74 | 16.61 | 22.7 | 10.94 |
Other Long-Term Liabilities | 2.15 | 3.41 | 0.04 | 1.88 | 2.55 | 3.72 |
Total Liabilities | 8.46 | 13.51 | 17.77 | 18.49 | 25.25 | 14.66 |
Common Stock | 5.04 | 5.04 | 12.3 | 10.06 | 10.06 | 6.86 |
Additional Paid-In Capital | 917.55 | 916.55 | 797.78 | 732.71 | 730.02 | 618.79 |
Retained Earnings | -886.05 | -880.96 | -772.11 | -676.04 | -562.72 | -449.88 |
Comprehensive Income & Other | - | - | 0 | -0 | -0 | -0 |
Shareholders' Equity | 36.54 | 40.63 | 37.97 | 66.73 | 177.36 | 175.78 |
Total Liabilities & Equity | 45 | 54.14 | 55.74 | 85.23 | 202.61 | 190.44 |
Net Cash (Debt) | 41 | 49.83 | 54.19 | 83.74 | 201.01 | 188.61 |
Net Cash Growth | 154.69% | -8.05% | -35.29% | -58.34% | 6.58% | 109.46% |
Net Cash Per Share | - | 2.76 | 4.86 | 8.32 | 28.52 | 42.27 |
Filing Date Shares Outstanding | - | 20.17 | 12.29 | 10.06 | 10.06 | 6.86 |
Total Common Shares Outstanding | - | 20.17 | 12.29 | 10.06 | 10.06 | 6.86 |
Working Capital | 38.69 | 44.04 | 38.01 | 68.61 | 179.9 | 179.47 |
Book Value Per Share | - | 2.01 | 3.09 | 6.63 | 17.63 | 25.62 |
Tangible Book Value | 36.54 | 40.63 | 37.97 | 66.73 | 177.36 | 175.78 |
Tangible Book Value Per Share | - | 2.01 | 3.09 | 6.63 | 17.63 | 25.62 |
Machinery | - | 2.02 | 2.02 | 2.02 | 2.02 | 2.02 |